Acceptable fetal dose using flattening filter-free volumetric arc therapy (FFF VMAT) in postoperative chemoradiotherapy of tongue cancer during pregnancy

Optimizing irradiation protocols for pregnant women is challenging, because there are few cases and a dearth of fetal dosimetry data. We cared for a 36-year-old pregnant woman with tongue cancer. Prior to treatment, we compared three intensity-modulated radiation therapy (IMRT) techniques, including...

Full description

Bibliographic Details
Main Authors: Wataru Takahashi, Kanabu Nawa, Akihiro Haga, Hideomi Yamashita, Toshikazu Imae, Mami Ogita, Kae Okuma, Osamu Abe, Keiichi Nakagawa
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Clinical and Translational Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630819301028
_version_ 1818461175504961536
author Wataru Takahashi
Kanabu Nawa
Akihiro Haga
Hideomi Yamashita
Toshikazu Imae
Mami Ogita
Kae Okuma
Osamu Abe
Keiichi Nakagawa
author_facet Wataru Takahashi
Kanabu Nawa
Akihiro Haga
Hideomi Yamashita
Toshikazu Imae
Mami Ogita
Kae Okuma
Osamu Abe
Keiichi Nakagawa
author_sort Wataru Takahashi
collection DOAJ
description Optimizing irradiation protocols for pregnant women is challenging, because there are few cases and a dearth of fetal dosimetry data. We cared for a 36-year-old pregnant woman with tongue cancer. Prior to treatment, we compared three intensity-modulated radiation therapy (IMRT) techniques, including helical tomotherapy, volumetric arc therapy (VMAT), and flattening-filter free VMAT (FFF-VMAT) using treatment planning software. FFF-VMAT achieved the minimum fetal exposure and was selected as the optimal modality. We prescribed 66 Gy to the involved nodes, 60 Gy to the tumor bed and ipsilateral neck, and 54 Gy to the contralateral neck over 33 fractions. To confirm the out-of-field exposure per fraction, surface doses and the rectal dose were measured during FFF-VMAT delivery. Postoperative chemoradiotherapy was delivered using IMRT and a cisplatin regimen. Without any shielding, the total fetal dose was 0.03 Gy, within the limits established by the ICRP. A healthy girl was born vaginally at 37 weeks’ gestation. Keywords: Pregnancy, Tongue cancer, Fetal dose, Intensity-modulated radiation therapy, Flattening filter-free
first_indexed 2024-12-14T23:41:58Z
format Article
id doaj.art-add36de95f2949e689048a985b012057
institution Directory Open Access Journal
issn 2405-6308
language English
last_indexed 2024-12-14T23:41:58Z
publishDate 2020-01-01
publisher Elsevier
record_format Article
series Clinical and Translational Radiation Oncology
spelling doaj.art-add36de95f2949e689048a985b0120572022-12-21T22:43:30ZengElsevierClinical and Translational Radiation Oncology2405-63082020-01-0120912Acceptable fetal dose using flattening filter-free volumetric arc therapy (FFF VMAT) in postoperative chemoradiotherapy of tongue cancer during pregnancyWataru Takahashi0Kanabu Nawa1Akihiro Haga2Hideomi Yamashita3Toshikazu Imae4Mami Ogita5Kae Okuma6Osamu Abe7Keiichi Nakagawa8Department of Radiology, The University of Tokyo Hospital, Tokyo, Japan; Corresponding author at: Department of Radiology, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.Department of Radiology, The University of Tokyo Hospital, Tokyo, JapanDepartment of Medical Image Informatics, Tokushima University, Tokushima, JapanDepartment of Radiology, The University of Tokyo Hospital, Tokyo, JapanDepartment of Radiology, The University of Tokyo Hospital, Tokyo, JapanDepartment of Radiology, The University of Tokyo Hospital, Tokyo, JapanDepartment of Radiology, The University of Tokyo Hospital, Tokyo, JapanDepartment of Radiology, The University of Tokyo Hospital, Tokyo, JapanDepartment of Radiology, The University of Tokyo Hospital, Tokyo, JapanOptimizing irradiation protocols for pregnant women is challenging, because there are few cases and a dearth of fetal dosimetry data. We cared for a 36-year-old pregnant woman with tongue cancer. Prior to treatment, we compared three intensity-modulated radiation therapy (IMRT) techniques, including helical tomotherapy, volumetric arc therapy (VMAT), and flattening-filter free VMAT (FFF-VMAT) using treatment planning software. FFF-VMAT achieved the minimum fetal exposure and was selected as the optimal modality. We prescribed 66 Gy to the involved nodes, 60 Gy to the tumor bed and ipsilateral neck, and 54 Gy to the contralateral neck over 33 fractions. To confirm the out-of-field exposure per fraction, surface doses and the rectal dose were measured during FFF-VMAT delivery. Postoperative chemoradiotherapy was delivered using IMRT and a cisplatin regimen. Without any shielding, the total fetal dose was 0.03 Gy, within the limits established by the ICRP. A healthy girl was born vaginally at 37 weeks’ gestation. Keywords: Pregnancy, Tongue cancer, Fetal dose, Intensity-modulated radiation therapy, Flattening filter-freehttp://www.sciencedirect.com/science/article/pii/S2405630819301028
spellingShingle Wataru Takahashi
Kanabu Nawa
Akihiro Haga
Hideomi Yamashita
Toshikazu Imae
Mami Ogita
Kae Okuma
Osamu Abe
Keiichi Nakagawa
Acceptable fetal dose using flattening filter-free volumetric arc therapy (FFF VMAT) in postoperative chemoradiotherapy of tongue cancer during pregnancy
Clinical and Translational Radiation Oncology
title Acceptable fetal dose using flattening filter-free volumetric arc therapy (FFF VMAT) in postoperative chemoradiotherapy of tongue cancer during pregnancy
title_full Acceptable fetal dose using flattening filter-free volumetric arc therapy (FFF VMAT) in postoperative chemoradiotherapy of tongue cancer during pregnancy
title_fullStr Acceptable fetal dose using flattening filter-free volumetric arc therapy (FFF VMAT) in postoperative chemoradiotherapy of tongue cancer during pregnancy
title_full_unstemmed Acceptable fetal dose using flattening filter-free volumetric arc therapy (FFF VMAT) in postoperative chemoradiotherapy of tongue cancer during pregnancy
title_short Acceptable fetal dose using flattening filter-free volumetric arc therapy (FFF VMAT) in postoperative chemoradiotherapy of tongue cancer during pregnancy
title_sort acceptable fetal dose using flattening filter free volumetric arc therapy fff vmat in postoperative chemoradiotherapy of tongue cancer during pregnancy
url http://www.sciencedirect.com/science/article/pii/S2405630819301028
work_keys_str_mv AT watarutakahashi acceptablefetaldoseusingflatteningfilterfreevolumetricarctherapyfffvmatinpostoperativechemoradiotherapyoftonguecancerduringpregnancy
AT kanabunawa acceptablefetaldoseusingflatteningfilterfreevolumetricarctherapyfffvmatinpostoperativechemoradiotherapyoftonguecancerduringpregnancy
AT akihirohaga acceptablefetaldoseusingflatteningfilterfreevolumetricarctherapyfffvmatinpostoperativechemoradiotherapyoftonguecancerduringpregnancy
AT hideomiyamashita acceptablefetaldoseusingflatteningfilterfreevolumetricarctherapyfffvmatinpostoperativechemoradiotherapyoftonguecancerduringpregnancy
AT toshikazuimae acceptablefetaldoseusingflatteningfilterfreevolumetricarctherapyfffvmatinpostoperativechemoradiotherapyoftonguecancerduringpregnancy
AT mamiogita acceptablefetaldoseusingflatteningfilterfreevolumetricarctherapyfffvmatinpostoperativechemoradiotherapyoftonguecancerduringpregnancy
AT kaeokuma acceptablefetaldoseusingflatteningfilterfreevolumetricarctherapyfffvmatinpostoperativechemoradiotherapyoftonguecancerduringpregnancy
AT osamuabe acceptablefetaldoseusingflatteningfilterfreevolumetricarctherapyfffvmatinpostoperativechemoradiotherapyoftonguecancerduringpregnancy
AT keiichinakagawa acceptablefetaldoseusingflatteningfilterfreevolumetricarctherapyfffvmatinpostoperativechemoradiotherapyoftonguecancerduringpregnancy